FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W285475215> ?p ?o ?g. }

• W285475215 endingPage "821" @default.
• W285475215 startingPage "814" @default.
• W285475215 abstract "Background Excessive deposition of extracellular matrix (ECM) in the kidney is the hallmark of diabetic nephropathy. Increased matrix synthesis has been well documented but the effects of diabetes on degradative pathways, particularly in the in vivo setting. The renal protective effect of these pathways on matrix accumulation has not been fully elucidated. The present study was understaken to investigate the activity of matrix metalloproteinase-2 (MMP-2), the expression of MMP-2 and tissue inhibitor of metalloproteinase-2 (TIMP-2) in kidney tissues of diabetic rats, and to explore the degradative pathway of type IV collagen (IV-C) and the renal protective effects of ACE inhibition—benazepril. Methods Twenty-four healthy male Wistar rats were divided randomly into normal control group (NC group), untreated diabetes mellitus group (DM group), and diabetes mellitus group treated with benazepril (DL group). The rat model of diabetes mellitus was induced by intraperitoneal injection of streptozocin (60 mg/kg). After the establishment of DM model, benazepril (10 mg ·kg-1 ·d-1) was given to the DL group for 12 weeks, and the same volume of water was given to the other two groups. At the end of 12 weeks, renal function was evaluated with 24-hour urinary protein (Upro), clearance of creatinine (Ccr), and blood urea nitrogen (BUN). MMP-2 activity was determined by gelatin zymography. The levels of MMP-2,TIMP-2 and collagen IV (IV-C) protein in the kidney tissue were assessed by immunohistochemistry. The gene expression of MMP-2 and TIMP-2 was measured by reverse transcription polymerase chain reaction (RT-PCR). Results The levels of BUN, Upro and Ccr in the DM group were higher than those in the NC group. In the DM group, the mRNA, enzymatic activity and proteins of MMP-2 decreased, but the expressions of IV-C and TIMP-2 increased. All diabetes-associated changes in renal function and MMP/TIMP were attenuated after benazepril treatment with reduced IV-C accumulation. Conclusions The changes of MMP-2 and TIMP-2 expressions in kidney tissues of diabetes rats may contribute to the occurrence and progression of diabetic nephropathy. Benazepril could exert protective effects on diabetic nephropathy, owing to the upregulation of MMP-2 and downregulation of TIMP-2 expressions, which further inhibits the excessive deposition of extracellular matrix in the glomerulus." @default.
• W285475215 created "2016-06-24" @default.
• W285475215 creator A5018359779 @default.
• W285475215 creator A5025570970 @default.
• W285475215 creator A5044929614 @default.
• W285475215 creator A5048758517 @default.
• W285475215 creator A5049560731 @default.
• W285475215 creator A5058453644 @default.
• W285475215 date "2006-05-01" @default.
• W285475215 modified "2023-10-13" @default.
• W285475215 title "Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats" @default.
• W285475215 cites W1935587632 @default.
• W285475215 cites W1980295850 @default.
• W285475215 cites W1982205510 @default.
• W285475215 cites W1983244507 @default.
• W285475215 cites W1986639245 @default.
• W285475215 cites W1987663852 @default.
• W285475215 cites W1991079098 @default.
• W285475215 cites W2004695078 @default.
• W285475215 cites W2005482739 @default.
• W285475215 cites W2011409573 @default.
• W285475215 cites W2016257140 @default.
• W285475215 cites W2017795402 @default.
• W285475215 cites W2037670681 @default.
• W285475215 cites W2057093763 @default.
• W285475215 cites W2059996061 @default.
• W285475215 cites W2062036646 @default.
• W285475215 cites W2073574105 @default.
• W285475215 cites W2075525736 @default.
• W285475215 cites W2082912485 @default.
• W285475215 cites W2112528128 @default.
• W285475215 cites W2126813766 @default.
• W285475215 cites W2142577667 @default.
• W285475215 cites W2146733325 @default.
• W285475215 cites W2164778548 @default.
• W285475215 cites W2188901193 @default.
• W285475215 doi "https://doi.org/10.1097/00029330-200605020-00004" @default.
• W285475215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16732983" @default.
• W285475215 hasPublicationYear "2006" @default.
• W285475215 type Work @default.
• W285475215 sameAs 285475215 @default.
• W285475215 citedByCount "48" @default.
• W285475215 countsByYear W2854752152012 @default.
• W285475215 countsByYear W2854752152013 @default.
• W285475215 countsByYear W2854752152014 @default.
• W285475215 countsByYear W2854752152015 @default.
• W285475215 countsByYear W2854752152016 @default.
• W285475215 countsByYear W2854752152017 @default.
• W285475215 countsByYear W2854752152019 @default.
• W285475215 countsByYear W2854752152020 @default.
• W285475215 countsByYear W2854752152021 @default.
• W285475215 countsByYear W2854752152022 @default.
• W285475215 countsByYear W2854752152023 @default.
• W285475215 crossrefType "journal-article" @default.
• W285475215 hasAuthorship W285475215A5018359779 @default.
• W285475215 hasAuthorship W285475215A5025570970 @default.
• W285475215 hasAuthorship W285475215A5044929614 @default.
• W285475215 hasAuthorship W285475215A5048758517 @default.
• W285475215 hasAuthorship W285475215A5049560731 @default.
• W285475215 hasAuthorship W285475215A5058453644 @default.
• W285475215 hasBestOaLocation W2854752151 @default.
• W285475215 hasConcept C109523444 @default.
• W285475215 hasConcept C126322002 @default.
• W285475215 hasConcept C134018914 @default.
• W285475215 hasConcept C159641895 @default.
• W285475215 hasConcept C2775965246 @default.
• W285475215 hasConcept C2777363265 @default.
• W285475215 hasConcept C2779922275 @default.
• W285475215 hasConcept C2780091579 @default.
• W285475215 hasConcept C2780159080 @default.
• W285475215 hasConcept C2780306776 @default.
• W285475215 hasConcept C555293320 @default.
• W285475215 hasConcept C71924100 @default.
• W285475215 hasConcept C84393581 @default.
• W285475215 hasConceptScore W285475215C109523444 @default.
• W285475215 hasConceptScore W285475215C126322002 @default.
• W285475215 hasConceptScore W285475215C134018914 @default.
• W285475215 hasConceptScore W285475215C159641895 @default.
• W285475215 hasConceptScore W285475215C2775965246 @default.
• W285475215 hasConceptScore W285475215C2777363265 @default.
• W285475215 hasConceptScore W285475215C2779922275 @default.
• W285475215 hasConceptScore W285475215C2780091579 @default.
• W285475215 hasConceptScore W285475215C2780159080 @default.
• W285475215 hasConceptScore W285475215C2780306776 @default.
• W285475215 hasConceptScore W285475215C555293320 @default.
• W285475215 hasConceptScore W285475215C71924100 @default.
• W285475215 hasConceptScore W285475215C84393581 @default.
• W285475215 hasIssue "10" @default.
• W285475215 hasLocation W2854752151 @default.
• W285475215 hasLocation W2854752152 @default.
• W285475215 hasOpenAccess W285475215 @default.
• W285475215 hasPrimaryLocation W2854752151 @default.
• W285475215 hasRelatedWork W2068642987 @default.
• W285475215 hasRelatedWork W2348460917 @default.
• W285475215 hasRelatedWork W2353943491 @default.
• W285475215 hasRelatedWork W2354885622 @default.
• W285475215 hasRelatedWork W2361798687 @default.
• W285475215 hasRelatedWork W2373145670 @default.

• next